Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author ASSONE, Tatiane FMUSP-HC
PAIVA, Arthur FMUSP-HC
FONSECA, Luiz Augusto M. FMUSP-HC
CASSEB, Jorge FMUSP-HC
dc.date.issued 2016
dc.identifier.citation VIRUSES-BASEL, v.8, n.2, article ID 38, 17p, 2016
dc.identifier.issn 1999-4915
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/14599
dc.description.abstract Human T-cell leukemia virus type 1 (HTLV-1), hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) are prevalent worldwide, and share similar means of transmission. These infections may influence each other in evolution and outcome, including cancer or immunodeficiency. Many studies have reported the influence of genetic markers on the host immune response against different persistent viral infections, such as HTLV-1 infection, pointing to the importance of the individual genetic background on their outcomes. However, despite recent advances on the knowledge of the pathogenesis of HTLV-1 infection, gaps in the understanding of the role of the individual genetic background on the progress to disease clinically manifested still remain. In this scenario, much less is known regarding the influence of genetic factors in the context of dual or triple infections or their influence on the underlying mechanisms that lead to outcomes that differ from those observed in monoinfection. This review describes the main factors involved in the virus-host balance, especially for some particular human leukocyte antigen (HLA) haplotypes, and other important genetic markers in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and other persistent viruses, such as HIV and HCV.
dc.description.sponsorship · CNPq [234058/2014-5]
· FAPESP [2012/23397-0, 2014/22827-7]
dc.language.iso eng
dc.publisher MDPI AG
dc.relation.ispartof Viruses-Basel
dc.rights openAccess
dc.subject HTLV-1; HIV-1; HCV; genetic factors
dc.subject.other hepatitis-c virus; cell lymphotropic virus; human-immunodeficiency-virus; long-term nonprogressors; human-leukocyte antigen; class-i alleles; myelopathy/tropical spastic paraparesis; intravenous-drug-users; hla-b region; disease progression
dc.title Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections
dc.type article
dc.rights.holder Copyright MDPI AG
dc.description.group LIM/38
dc.description.group LIM/56
dc.identifier.doi 10.1016/J.VIROL.2012.09.028; 10.3390/v8020038
dc.identifier.pmid 26848682
dc.type.category review
dc.type.version publishedVersion
hcfmusp.author ASSONE, Tatiane:IMT:
hcfmusp.author PAIVA, Arthur:IMT:
hcfmusp.author FONSECA, Luiz Augusto M.:HC:ICHC
hcfmusp.author CASSEB, Jorge:IMT:IMT
hcfmusp.origem.id 2-s2.0-84957553359
hcfmusp.origem.id WOS:000371831800024
hcfmusp.publisher.city BASEL
hcfmusp.publisher.country SWITZERLAND
hcfmusp.relation.reference · Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06
· An P, 2014, J INFECT DIS, V210, P1539, DOI 10.1093/infdis/jiu291
· KOZIEL MJ, 1992, J IMMUNOL, V149, P3339
· Teixeira SLM, 2014, GENES IMMUN, V15, P256, DOI 10.1038/gene.2014.14
· de Vasconcelos JM, 2013, GENET MOL BIOL, V36, P22, DOI 10.1590/S1415-47572013000100004
· Sobesky M, 2000, PRESSE MED, V29, P413
· Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
· Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229
· Machmach K, 2013, J INFECT DIS, V207, P651, DOI 10.1093/infdis/jis717
· Deschamps R, 2010, INT J INFECT DIS, V14, pE986, DOI 10.1016/j.ijid.2010.05.020
· BARTHOLOMEW C, 1987, LANCET, V2, P1469
· Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135
· MAGNANI G, 1995, INFECTION, V23, P63, DOI 10.1007/BF01710063
· Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948
· Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399
· Stewart GJ, 1997, AIDS, V11, P1833, DOI 10.1097/00002030-199715000-00007
· Casoli C, 2000, BLOOD, V95, P2760
· Sanabani SS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-374
· Nasi M, 2013, INT J INFECT DIS, V17, pE845, DOI 10.1016/j.ijid.2013.01.003
· Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845
· Sabouri AH, 2005, J GEN VIROL, V86, P773, DOI 10.1099/vir.0.80509-0
· Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/01.aids.0000096870.36052.b6
· Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101
· Singh KK, 2005, J INFECT DIS, V191, P1971, DOI 10.1086/430091
· [Anonymous], 2012, VIROL J, DOI 10.1186/1743-422X-9-40
· Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670
· Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6
· Cole AM, 2003, CURR PHARM DESIGN, V9, P1463, DOI 10.2174/1381612033454667
· Beilke MA, 2004, CLIN INFECT DIS, V39, P256, DOI 10.1086/422146
· Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146
· Lewis MJ, 2000, J IMMUNOL, V165, P4127
· Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
· Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489
· Jacobson Steven, 1997, Leukemia (Basingstoke), V11, P73
· Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200
· Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848
· Brites C, 2009, AIDS REV, V11, P8
· Ballana E, 2012, IMMUNOBIOLOGY, V217, P889, DOI 10.1016/j.imbio.2011.12.012
· Phillips EJ, 2005, AIDS, V19, P979, DOI 10.1097/01.aids.0000171414.99409.fb
· Balistrieri G, 2013, VIRAL IMMUNOL, V26, P3, DOI 10.1089/vim.2012.0060
· [Anonymous], 2010, J TRANSL MED S1, DOI 10.1186/1479-5876-9-S1-S9
· Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463
· Trevino A, 2012, CLIN INFECT DIS, V55, pE1, DOI 10.1093/cid/cis343
· Chatterjee A, 2012, DIS MARKERS, V32, P143, DOI 10.3233/DMA-2011-0874
· Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X
· Cocchi F, 2000, P NATL ACAD SCI USA, V97, P13812, DOI 10.1073/pnas.240469997
· Jeffery KJM, 2000, J IMMUNOL, V165, P7278
· Bangham CRM, 1999, PHILOS T ROY SOC B, V354, P691, DOI 10.1098/rstb.1999.0422
· Gong XH, 2015, INFECT GENET EVOL, V34, P137, DOI 10.1016/j.meegid.2015.07.012
· Smith MW, 1997, NAT MED, V3, P1052, DOI 10.1038/nm1097-1052c
· Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274
· Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1
· Numasaki M, 2007, J IMMUNOL, V178, P5086
· Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004
· Gao XJ, 2010, AIDS, V24, P1835, DOI 10.1097/QAD.0b013e32833c3219
· Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400
· Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874
· Ruggero K, 2010, MOL ASPECTS MED, V31, P367, DOI 10.1016/j.mam.2010.05.001
· Hendel H, 1999, J IMMUNOL, V162, P6942
· COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000
· Montanheiro PA, 2009, SCAND J IMMUNOL, V70, P403, DOI 10.1111/j.1365-3083.2009.02291.x
· CIMARELLI A, 1995, J ACQ IMMUN DEF SYND, V10, P198
· Goedert JJ, 2007, INT J CANCER, V121, P1092, DOI 10.1002/ijc.22767
· Borducchi DM, 2003, BRIT J HAEMATOL, V123, P954, DOI 10.1046/j.1365-2141.2003.04711.x
· Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397
· de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541
· KLEIN MR, 1994, J INFECT DIS, V169, P1244
· Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092
· Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203
· Bassani S, 2007, CLIN INFECT DIS, V44, P105, DOI 10.1086/510076
· Ferbas J, 2000, J INFECT DIS, V182, P1247, DOI 10.1086/315849
· Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477
· Bovolenta C, 2002, BLOOD, V99, P224, DOI 10.1182/blood.V99.1.224
· Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856
· Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405
· Julg B, 2011, J INFECT DIS, V203, P803, DOI 10.1093/infdis/jiq122
· Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621
· Trevino A, 2013, J NEUROL, V260, P2551, DOI 10.1007/s00415-013-7014-z
· Cardoso DF, 2009, REV I MED TROP, V51, P325, DOI [10.1590/S0036-46652009000600004, 10.1590/S0036-46652009000600003]
· Schinkel J, 1999, J INFECT DIS, V179, P825, DOI 10.1086/314658
· Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100
· Michael NL, 1997, LANCET, V350, P741, DOI 10.1016/S0140-6736(05)63552-0
· IRVING SG, 1990, NUCLEIC ACIDS RES, V18, P3261, DOI 10.1093/nar/18.11.3261
· Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05
· Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447
· Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
· ZACK JA, 1988, SCIENCE, V240, P1026, DOI 10.1126/science.2835813
· Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860
· Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
· Sato A, 2006, J IMMUNOL, V176, P7686
· [Anonymous], 2009, PLOS COMPUT BIOL, DOI 10.1371/JOURNAL.PCBI.1000327
· Catalan-Soares BC, 2009, MED MICROBIOL IMMUN, V198, P1, DOI 10.1007/s00430-008-0096-z
· Vidal F, 2005, JAIDS-J ACQ IMM DEF, V40, P527, DOI 10.1097/01.qai.0000186362.50457.e0
· Weinberg A, 2006, Adv Dent Res, V19, P42
· Mohd Hanafiah Khayriyyah, 2013, Hepatology, V57, P1333, DOI 10.1002/hep.26141
· Shebl FM, 2011, J INFECT DIS, V204, P1843, DOI 10.1093/infdis/jir647
· Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8
· Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481
· Ullum H, 1998, J INFECT DIS, V177, P331
· Antoni G, 2013, AIDS, V27, P1707, DOI 10.1097/QAD.0b013e328360a4bd
· Assone T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003199
· Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636
· De Re V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117420
· Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
· Imanishi T., 1992, HLA 1991, P1065
· FERRI C, 1994, EUR J CLIN INVEST, V24, P781, DOI 10.1111/j.1365-2362.1994.tb01077.x
· Kamihira S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-40
· Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52
· MacNamara A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001117
· Moroni M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0335-6
· National Institutes of Health, 2002, GASTROENTEROLOGY, V123, P2082, DOI 10.1053/GAST.2002.1232082
· Aka PV, 2014, J INFECT DIS, V209, P350, DOI 10.1093/infdis/jit433
· Ramana GV, 2001, J GENET, V80, P137, DOI 10.1007/BF02717909
· Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699
· Schwartz O, 2007, NAT MED, V13, P245, DOI 10.1038/nm0307-245
· Taghaddosi M, 2013, IRAN J BASIC MED SCI, V16, P264
· Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347
dc.description.index MEDLINE
hcfmusp.citation.scopus 6
hcfmusp.citation.wos 7


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics